Timmerman Traverse for Life Science Cares 2022
The Timmerman Traverse for Life Science Cares
A team of 20 life science executives came together to hike the Presidential Traverse in September 2022. It’s a three-day, 20-mile hike that covers rocky terrain and 8,000 feet of net elevation gain in the White Mountains of New Hampshire. Our goal was to raise more $800,000 to combat poverty through Life Science Cares.
Together, we raised more than $960,000.
This year’s hikers, led by Traverse founder Luke Timmerman of the biotech journalism outlet Timmerman Report, dedicated their campaigns to serving communities in Greater Boston, Philadelphia, San Diego, and the San Francisco Bay Area.
When?
Sept. 12-14, 2022
Who?
- Luke Timmerman, founder, Timmerman Report
- Katherine Andersen, Head of Life Sciences, Silicon Valley Bank
- Chip Clark, former CEO, Genocea Biosciences
- Sue Hager, Chief Marketing Officer, A16Z
- Alex Harding, Senior Vice President, Business Development, Remix Therapeutics
- Bernat Olle, CEO, Vedanta Biosciences
- Mark Murcko, Founding CSO, Dewpoint Therapeutics
- Amanda Banks, Advisor, Harbinger Health
- Julie Sunderland, Managing Director, Biomatics Capital
- Parag Shah, CEO, K2 HealthVentures
- Lalo Flores, CEO, Century Therapeutics
- Bonnie Anderson, Founder and executive chairwoman, Veracyte
- Deb Palestrant, Partner, 5AM Ventures
- Doug Fambrough, Founder & former CEO, Dicerna Pharmaceuticals
- Dave Melville, Founder and CEO, The Bowdoin Group
- Art Krieg, Founder and CSO, Checkmate Pharmaceuticals
- Nina Kjellson, General Partner, Canaan Partners
- Mostafa Ronaghi, Executive Chairman & Co-founder, Cellanome
- Jennifer McNealey, former CFO, Codex DNA
- Ashvin Bashyam, R&D strategy, Ensoma
How can I support the cause?
Go to JustGiving.
Sponsors:
Life Science Cares Gallery
About Luke Timmerman
Who am I?
Luke Timmerman is a biotech journalist, author, and entrepreneur. I’m the founder of Timmerman Report, a biotech newsletter, and author of “Hood: Trailblazer of the Genomics Age.” My mountain climbing campaigns have raised $5.1 million for cancer research and the fight against poverty since 2017.
Why The Timmerman Traverse?
From Life Science Cares:
“The Timmerman Traverse benefitting Life Science Cares will take an intrepid group of hikers 23 miles across the Presidential Traverse in the White Mountains over the course of three days. Our team of 20 leaders in the life science sector have all committed to raise $25,000 and cumulatively raise $800,000 for Life Science Cares and our network of 27 partner nonprofit organizations.
Our partner nonprofits apply the very best research based solutions to helping our neighbors on the path to self-sufficiency. Paired with volunteer hours as well as hundreds of thousands of dollars in donated goods, Life Science Cares is a strong partner to these organizations, supporting them every step of the way.
To date, the Life Science Cares network has distributed more than $4.5 million in grants and performed 12,000 volunteer hours to support human service organizations in Greater Boston and Philadelphia. We’re on track to grow exponentially with the addition of affiliate sites in San Diego and the Bay Area launched in 2021.”
Team Details
Who’s On The Team?
- Luke Timmerman, founder, Timmerman Report
- Katherine Andersen, Head of Life Sciences, Silicon Valley Banks
- Chip Clark, former CEO, Genocea Biosciences
- Sue Hager, Chief Marketing Officer, A16Z
- Alex Harding, Entrepreneur in Residence, Atlas Venture
- Bernat Olle, CEO, Vedanta Biosciences
- Mark Murcko, Founding CSO, Dewpoint Therapeutics
- Amanda Banks, Advisor, Harbinger Health
- Julie Sunderland, Managing Director, Biomatics Capital
- Parag Shah, CEO, K2 HealthVentures
- Lalo Flores, CEO, Century Therapeutics
- Bonnie Anderson, Founder and executive chairwoman, Veracyte
- Deb Palestrant, Partner, 5AM Ventures
- Doug Fambrough, Founder & former CEO, Dicerna Pharmaceuticals
- Dave Melville, Founder and CEO, The Bowdoin Group
- Art Krieg, Founder and CSO, Checkmate Pharmaceuticals
- Nina Kjellson, General Partner, Canaan Partners
- Mostafa Ronaghi, Executive Chairman & Co-founder, Cellanome
- Jennifer McNealey, former CFO, Codex DNA
- Ashvin Bashyam, R&D strategy, Ensoma
Comments from Expedition Veterans
“What was completely unexpected on our Kilimanjaro trip was the level of camaraderie that immediately formed in the group – like-minded, interesting and interested, generous and unquitting”
“The proposition: join Luke and equal numbers of men & women in our industry to raise money for cancer research at the Fred Hutch and climb Mt. Kilimanjaro. This was the experience of a lifetime. Breathtaking scenery – yes. Challenging physically – yes. Outstanding guides & support personnel – yes. Life-long bonding experiences – yes!”
“Luke’s Climb to Fight Cancer trip to Kilimanjaro was simply the best chance ever to get to know a high quality group of biotech executives well. And so much more. Consider his future trips if you love the industry and hate cancer.”
The Climb to Fight Cancer EBC trip was life changing on many levels, personally and professionally. I applaud and thank Luke Timmerman who is an entrepreneurial leader with an ability to build a diverse, cohesive team motivated to give back.